|
03 Feb 2020 |
CEPI and GSK announce collaboration to strengthen the global effort to develop a vaccine for the 2019-nCoV virus
|
|
02 Feb 2020 |
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
|
|
02 Feb 2020 |
CureVac and CEPI extend their Cooperation to Develop a Vaccine against Coronavirus nCoV-2019
|
|
02 Feb 2020 |
Vaxart Announces Initiation of Coronavirus Vaccine Program
|
|
02 Feb 2020 |
Emergent BioSolutions Receives Positive CHMP Opinion for Vaxchora; Anticipates Near-Term Approval by European Medicines Agency
|
|
02 Feb 2020 |
FDA Approves Aimmune’s PALFORZIA™ as First Treatment for Peanut Allergy
|
|
30 Jan 2020 |
Inovio collaborating with Beijing Advaccine to advance INO-4800 vaccine against new coronavirus in China
|
|
30 Jan 2020 |
Tonix Pharmaceuticals Presented Results from a Preclinical Study of TNX-801, a Potential Vaccine to Prevent Smallpox and Monkeypox, in a Poster Presentation at the 2020 American Society for Microbiology (ASM) Biothreats Conference
|
|
30 Jan 2020 |
Geneos Personalized Neoantigen-Targeting Vaccine (GNOS-PV02) to be Utilized in Innovative GT-30 Hepatocellular Carcinoma Trial
|
|
28 Jan 2020 |
Researchers Present Positive Interim Data on Appili Therapeutics’ ATI-1701 Biodefense Program at 2020 ASM Biothreats
|
|
28 Jan 2020 |
Clover Initiates Development of Recombinant Subunit-Trimer Vaccine for Wuhan Coronavirus (2019-nCoV)
|
|
28 Jan 2020 |
GSK licenses tuberculosis vaccine candidate to the Bill & Melinda Gates Medical Research Institute for continued development
|
|
27 Jan 2020 |
GeoVax and BravoVax (Wuhan, China) to Collaborate on Development of Coronavirus Vaccine
|
|
23 Jan 2020 |
Inovio Selected by CEPI to Develop Vaccine Against New Coronavirus
|
|
23 Jan 2020 |
Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
|
|
23 Jan 2020 |
CEPI to fund three programmes to develop vaccines against the novel coronavirus, nCoV-2019
|
|
21 Jan 2020 |
Anokion Announces FDA Clearance of IND Application for its Lead Program in Celiac Disease
|
|
12 Jan 2020 |
Positive Final 2-Year Topline Data in Completed DC Vaccine Phase I/II trial in AML Patients
|
|
09 Jan 2020 |
SELLAS Commences Pivotal Phase 3 REGAL Study of Galinpepimut-S (GPS) in Patients with Acute Myeloid Leukemia (AML)
|
|
09 Jan 2020 |
Phase I clinical trial results published for Invectys DNA Vaccine for Cancer using PharmaJet Needle-free injector
|
|
07 Jan 2020 |
Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers
|
|
30 Dec 2019 |
HOOKIPA Announces First Patient Dosed in Phase 1/2 Clinical Trial for HB-201 for the Treatment of Human Papillomavirus 16-Positive Cancers
|
|
27 Dec 2019 |
Sinovac Announces Approval of Varicella Vaccine for Prevention of Varicella-Zoster Virus (Chickenpox) in Children
|
|
20 Dec 2019 |
Vaccitech Oncology Limited Enters Collaboration with Cancer Research UK to Fund a Phase I/IIa Clinical Trial as First-Line NSCLC Therapy
|
|
20 Dec 2019 |
First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
|
